Bioage Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens Berman
Bioage Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens Berman . (MENAFN - GlobeNewsWire - Nasdaq) SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. ( ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108973909/Bioage-Labs-BIOA-Azelaprag-Trial-Halt-Raises-Questions-About-Pre-IPO-Disclosures-Hagens-Berman
2024-12-09
rss
(MENAFN - GlobeNewsWire - Nasdaq) SAN FRANCISCO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. ( ...
Bioage Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens Berman